by Frontiers in Immunology - Makoto Miyara | Feb 11, 2022 | News, Publications, Scientific Publications
The capacity of pre-existing immunity to human common coronaviruses (HCoV) to cross-protect against de novo COVID-19is yet unknown. In this work, we studied the sera of 175 COVID-19 patients, 76 healthy donors and 3 intravenous immunoglobulins (IVIG)...
by Editorial | Feb 8, 2022 | Nature Biotechnology, News
Advances in technology and changes to healthcare during the pandemic may finally realize the vision of patient-centric blood testing espoused by disgraced Theranos CEO Elizabeth Holmes. Read the full article here.
Recent Comments